Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study
Swen Hesse, Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Michael Rullmann(Max Planck Institute for Human Cognitive and Brain Sciences), Ralf Regenthal(Leipzig University), Julia Luthardt(Leipzig University), Katrin Arélin(Max Planck Institute for Human Cognitive and Brain Sciences), G Reissig(Leipzig University), Donald Lobsien(Defense Information Systems Agency), Mohammed K. Hankir(IFB Adiposity Diseases), Mandy Drabe(IFB Adiposity Diseases), Michael Stümvoll(IFB Adiposity Diseases), Mathias Faßhauer(Leipzig University), Marianne Patt, Franziska Zientek(Leipzig University), Georg‐Alexander Becker(Leipzig University), Matthias Blüher(Leipzig University), Philipp Meyer(Leipzig University), Wiebke Fenske(IFB Adiposity Diseases), Karsten Winter(Leipzig University), Anke Bresch(Leipzig University), Christian Schinke(Leipzig University)
European Journal of Nuclear Medicine and Molecular Imaging
November 18, 2015
Cited by 27
Related Papers
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Metabolically Healthy Obesity
|Endocrine Reviews|2020|995
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823